Daphne E. Jones - 01 May 2026 Form 4/A - Amendment Insider Report for AMN HEALTHCARE SERVICES INC (AMN)

Reporting relationship: Director
Issuer ticker: AMN
Reported as of: 01 May 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 09 Jul 2026, 16:52:47 UTC
Original report date: 04 May 2026
Prior SEC filing: 06 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Whitney M. Laughlin, as attorney-in-fact on behalf of Daphne E. Jones

Filing notes and source

Key filing fact

Daphne E. Jones filed Form 4/A - Amendment for AMN HEALTHCARE SERVICES INC (AMN) on 09 Jul 2026.

Key facts

This page summarizes Daphne E. Jones's Form 4/A - Amendment filing for AMN HEALTHCARE SERVICES INC (AMN).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 09 Jul 2026, 16:52.

Change

Previous filing in this sequence was filed on 06 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001475924 Primary reporting owner

Jones Daphne E

Relationship: Director
Address: C/O AMN HEALTHCARE SERVICES, INC., 12400 HIGH BLUFF DRIVE, SUITE 500, SAN DIEGO
Signature: /s/ Whitney M. Laughlin, as attorney-in-fact on behalf of Daphne E. Jones
Signature date: 09 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMN transaction

Common Stock

Options Exercise

Transaction value
Shares: +8,325
Change %: +107%
Price: $0.000000^*
Shares after: 16,124
Date: 01 May 2026
Ownership: by Trust
Footnotes: F1, F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AMN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -8,325
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 01 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,325
Exercise price
Footnotes: F4, F5, F6

AMN transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares: +8,304
Change %
Price: $0.000000^*
Shares after: 8,304
Date: 01 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,304
Exercise price
Footnotes: F6, F7, F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

Footnote F2

Due to an administrative error, the Form 4 filed by the reporting person on May 4, 2026 overstated the amount of securities beneficially owned following the reported transaction by 1,000 shares. This Form 4 is being amended and restated to reflect that, following the reported transaction, 16,124 securities were beneficially owned by reporting person, not 17,124 as previously reported.

Footnote F3

These shares are held in the Daphne E. Jones Revocable Trust, of which the Reporting Person is the sole trustee and the sole beneficiary.

Footnote F4

The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

Footnote F5

The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026.

Footnote F6

RSUs do not have an expiration date.

Footnote F7

The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

Footnote F8

The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company.